Acino is a Swiss pharmaceutical company based in Zurich, established in 1836. It focuses on developing, manufacturing, and marketing innovative pharmaceuticals, particularly in novel drug delivery forms like modified-release and oral dispersible technologies. The company operates in over 90 high-growth emerging markets, including the Middle East, Africa, and Latin America.

Acino's product portfolio spans several therapeutic areas, including gastroenterology, oncology, and respiratory health. It offers both branded and generic medicines, aiming to improve patient access to affordable healthcare. The company has multiple manufacturing sites in Switzerland, Ukraine, Estonia, the UAE, and South Africa, which support its global supply chain and contract manufacturing services.

Additionally, Acino provides business-to-business services such as product development and out-licensing. As part of the Arcera group, Acino is committed to promoting affordable healthcare solutions and enhancing patient outcomes through its innovative medicines and strategic market presence.